助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   晚期肺腺癌 的翻译结果: 查询用时:0.012秒
图标索引 在分类学科中查询
所有学科
肿瘤学
更多类别查询

图标索引 历史查询
 

晚期肺腺癌
相关语句
  advanced lung adenocarcinoma
     Conclusion CAP combined with verapamil can improve the effect of chemotherapy in the treatment of patients with advanced lung adenocarcinoma.
     结论 CAP联合维拉帕米治疗可提高晚期肺腺癌的化疗效果 ,延长患者生存期 ,毒副反应可以耐受 ,具有进一步推广应用价值。
短句来源
     Treatment effects of CAP combined with verapamil in chemotherapy of patients with advanced lung adenocarcinoma
     CAP方案联合维拉帕米治疗晚期肺腺癌疗效分析
短句来源
     Comparison of ICE and CCE regimens for treatment of advanced lung adenocarcinoma
     ICE和CCE方案治疗晚期肺腺癌的疗效比较
短句来源
     Clinical Observation on the Treatment of Advanced Lung Adenocarcinoma with EMMP plus Irradiatesensitive of He-Ne Laser in Blood Vessel
     EMMP方案配合氦-氖(He-Ne)激光增敏治疗晚期肺腺癌的临床观察
短句来源
     Objective The therapeutic effects and side effects of combined chemotherapy of HCPT, MTX, LV and 5 Fu for Advanced Lung adenocarcinoma were evaluated.
     目的 本文观察了羟基喜树碱 (HCPT)、氨甲蝶呤 (MTX)、5 氟脲嘧啶 (5 Fu)和醛氢叶酸钙(LV)联合方案治疗晚期肺腺癌的疗效及毒副作用。
短句来源
更多       
  advanced pulmonary adenocarcinoma
     Comparison between taxol plus carboplatin and taxol plus cisplatin in treatment of advanced pulmonary adenocarcinoma
     泰素加卡铂与泰素加顺铂治疗晚期肺腺癌的比较
短句来源
     Objective To evaluate and compare the efficacy and toxicity of taxol plus carboplatin and tax-ol plus cisplatin on the treatment of advanced pulmonary adenocarcinoma.
     目的 观察比较泰素加卡铂与泰素加顺铂治疗晚期肺腺癌的近期疗效及不良反应。
短句来源
     Methods Thirty-five patients with advanced pulmonary adenocarcinoma were randomized into taxol plus carboplatin group (group A) and taxol plus cisplatin group (group B). Efficacies and toxicities were assessed after 2 cycles of treatment for individual patient.
     方法 35例晚期肺腺癌患者随机分为Taxol+CRP组(A组)及Taxol+DDP组(B组),治疗2个周期后进行疗效及不良反应的评估。
短句来源
     Conclusion Both taxol plus carboplatin and taxol plus cisplatin regimens are effective for treatment of advanced pulmonary adenocarcinoma.
     结论 Taxol+CBP及Taxol+DDP在治疗晚期肺腺癌方面均有较好疗效,不良反应可耐受。
短句来源
  “晚期肺腺癌”译为未确定词的双语例句
     Clinical Observation on 24 Cases with Advanced Lung Cancerwith NP Regiment
     NP方案治疗晚期肺腺癌24例临床观察
短句来源
     Clinical Research on Combination Scheme with Hydroxycamptothecin for treatment of Lung Adenocarcinoma
     羟基喜树碱联合方案治疗晚期肺腺癌的临床研究
短句来源
     One year survival rate was 41%, Main median survival interval was 11 months.
     结果 HMLF方案治疗晚期肺腺癌5 1例 ,总有效率 49% ,1年生存率 41% ,中位生存期为 11个月。
短句来源
     Clinical observation on advanced stage adenocarcinoma of lung treated with gefitinib after failure of chemotherapy
     吉非替尼治疗化疗失败晚期肺腺癌的临床观察
短句来源
     Conclusions The EPH scheme is a good selection for therapy lung adenocarcinoma.
     结论 EPH是治疗晚期肺腺癌的一个可选方案。
短句来源
更多       
查询“晚期肺腺癌”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  advanced lung adenocarcinoma
We report a case of a partial response in a 76-year-old never-smoker female affected by advanced lung adenocarcinoma refractory to first- and second-line chemotherapy.
      


Seven patients with stage Ⅲ-Ⅳ pulmonary carcinoma were treated with bron- chial artery infusion of high-dose MTX (5-10g). Of these, partial remission were not- ed in 2 cases, stable disease in 2, and progressive disease in 3. In addition, 2 metas- tatic lung lesions of osteosarcoma with pleural effusion were also treated likewise and which resulted in complete remission in 1 and partial remission in the other. It is recommended that patients with far advanced lung cancer might be treated with bron- cllial artery...

Seven patients with stage Ⅲ-Ⅳ pulmonary carcinoma were treated with bron- chial artery infusion of high-dose MTX (5-10g). Of these, partial remission were not- ed in 2 cases, stable disease in 2, and progressive disease in 3. In addition, 2 metas- tatic lung lesions of osteosarcoma with pleural effusion were also treated likewise and which resulted in complete remission in 1 and partial remission in the other. It is recommended that patients with far advanced lung cancer might be treated with bron- cllial artery infusion of high-dose MTX.

本文报告用HD-MTX(5~10g)经支气管动脉灌注治疗晚期肺腺癌7例、骨肉瘤术后两肺广泛转移伴胸水2例,结果7例肺癌中,部分缓解2例、稳定2例、进展恶化3例;1例骨肉瘤肺转移伴胸水完全缓解,另1例胸水消失、肿瘤部分缓解。认为用HD-MTX经支气管动脉灌注治疗晚期肺癌不失为一种可供选择的治疗方法。

A randomized trial of MFP and CAP protocols in 67 cases of advanced lung adenocarcinoma was performed during the period January 1985 to December 1987. The response rates of MFP and CAP were 46. 9% and 25. 7% respectively (P>0. 05%). The toxic effects on digestive tract were similar between the two groups (P>0. 05). however, the hematological toxicities in CAP group were more severe than those in MFP group(P<0. 01). A 2-year fol- low-up showed that the median survival time of MFP group was longer (9. 5 months...

A randomized trial of MFP and CAP protocols in 67 cases of advanced lung adenocarcinoma was performed during the period January 1985 to December 1987. The response rates of MFP and CAP were 46. 9% and 25. 7% respectively (P>0. 05%). The toxic effects on digestive tract were similar between the two groups (P>0. 05). however, the hematological toxicities in CAP group were more severe than those in MFP group(P<0. 01). A 2-year fol- low-up showed that the median survival time of MFP group was longer (9. 5 months vs 7 months). It is suggested that the MFP protocol is more efficacious and less toxic and less expensive than CAP regimen and worths further study.

本文报告1985年1月~1987年12月随机分组应用MFP (32例)与CAP(35例)方案治疗晚期肺腺癌的有效率分别为46.9%及25.7%(无CR病例,P>0.05),CAP组较前者的血液学毒性差异有非常显著意义(P<0.01)。随访2年以上结果表明,MFP组中位生存期较长(9.5月/7月)。作者作为,MFP方案具有相对廉价、低毒及疗效较高的特点,值得临床进一步探讨。

Purpose:To evaluate the combined chemotherapy efficacy and toxicity of mitocycin, vindesine and cisplatin on ad-vanced lung adenocarcinoma. Method: 32 case of stage ? ~ IV lung adenocarcinoma were treated with MVP regimen unoperable , thatis mitomycin 6mg/m2, Vindesine 2. 5mg/m2,iv all seperatelly day 1,8. cisplatin 60~80mg/m2, iv drip, day 3, and enough solution need to be given intra venous infusion. The treatment was recycled every 21 days, and 3 cycles formed a theraputic couse. The theraputic effect was...

Purpose:To evaluate the combined chemotherapy efficacy and toxicity of mitocycin, vindesine and cisplatin on ad-vanced lung adenocarcinoma. Method: 32 case of stage ? ~ IV lung adenocarcinoma were treated with MVP regimen unoperable , thatis mitomycin 6mg/m2, Vindesine 2. 5mg/m2,iv all seperatelly day 1,8. cisplatin 60~80mg/m2, iv drip, day 3, and enough solution need to be given intra venous infusion. The treatment was recycled every 21 days, and 3 cycles formed a theraputic couse. The theraputic effect was evaluated ofter 2 cycles. Results:Partial response rate (13/32) was 40. 6%. The main side-ef-fects were nausea, vomiting and leukopenia. Conclusion:The MVP regimen is regarded as a better regimen for advanced lung adenocarcinoma.

目的:评价丝裂霉素、长春花碱酰胺和顺铂联合治疗晚期肺腺癌的疗效和毒性.方法:32例不能手术的肺腺癌Ⅲ~Ⅳ期,MVP方案化疗:丝裂霉素6mg/m~2,静脉冲入,第1、8天;长春花碱酰胺2.5mg/m~2,静脉冲入,第1、8天;顺铂60~80mg/m~2,静脉滴注,第3天,水化.每3周为一周期,二周期后评价疗效.结果:部分缓解率(12/32)40.6%.毒副反应主要为恶心、呕吐和白细胞下降.结论:MVP方案是治疗晚期肺腺癌疗效较高的方案.

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关晚期肺腺癌的内容
在知识搜索中查有关晚期肺腺癌的内容
在数字搜索中查有关晚期肺腺癌的内容
在概念知识元中查有关晚期肺腺癌的内容
在学术趋势中查有关晚期肺腺癌的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社